Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collier

Showing results (451-460 of 508) with videos related to

Pageof 51
Sort By:
The Journal of Infectious Diseases|May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic SubstudyMárton Kolossváry, Chris deFilippi, Michael T Lu, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 28, 2011
Family history of dementia predicts worse neuropsychological functioning among HIV-infected personsDavid J Moore, Miguel Arce, Suzanne Moseley, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
JAMA|April 13, 2001
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trialA C Collier, L A Kalish, M P Busch, et al.
Journal of the International Neuropsychological Society : JINS|October 3, 2019
Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain AbnormalitiesLaura M Campbell, Christine Fennema-Notestine, Rowan Saloner, et al.
Annals of Internal Medicine|February 16, 2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1Eric S Daar, Camlin Tierney, Margaret A Fischl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Journal of Virology|May 20, 2011
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processesJoshua T Herbeck, Morgane Rolland, Yi Liu, et al.
Pageof 51

Showing results (451-460 of 508) with videos related to

Sort By:
Pageof 51
The Journal of Infectious Diseases|May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic SubstudyMárton Kolossváry, Chris deFilippi, Michael T Lu, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 28, 2011
Family history of dementia predicts worse neuropsychological functioning among HIV-infected personsDavid J Moore, Miguel Arce, Suzanne Moseley, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
JAMA|April 13, 2001
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trialA C Collier, L A Kalish, M P Busch, et al.
Journal of the International Neuropsychological Society : JINS|October 3, 2019
Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain AbnormalitiesLaura M Campbell, Christine Fennema-Notestine, Rowan Saloner, et al.
Annals of Internal Medicine|February 16, 2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1Eric S Daar, Camlin Tierney, Margaret A Fischl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous systemScott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Journal of Virology|May 20, 2011
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processesJoshua T Herbeck, Morgane Rolland, Yi Liu, et al.
Pageof 51